ASK1 Is Essential for JNK/SAPK Activation by TRAF2

Slides:



Advertisements
Similar presentations
Casper Is a FADD- and Caspase-Related Inducer of Apoptosis
Advertisements

Volume 41, Issue 6, Pages (March 2011)
A TPR Motif Cofactor Contributes to p300 Activity in the p53 Response
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
Volume 11, Issue 4, Pages (April 2003)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 36, Issue 5, Pages (December 2009)
Volume 8, Issue 5, Pages (November 2001)
Volume 5, Issue 4, Pages (April 2004)
by Katriina J. Peltola, Kirsi Paukku, Teija L. T
Volume 9, Issue 1, Pages (January 2002)
Autoinhibition of c-Abl
Volume 11, Issue 3, Pages (September 1999)
Volume 87, Issue 7, Pages (December 1996)
Volume 8, Issue 16, Pages (July 1998)
Volume 23, Issue 1, Pages (July 2006)
A Mechanism for Inhibiting the SUMO Pathway
Volume 19, Issue 6, Pages (September 2005)
Volume 4, Issue 4, Pages (April 1996)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
The TRAF6 Ubiquitin Ligase and TAK1 Kinase Mediate IKK Activation by BCL10 and MALT1 in T Lymphocytes  Lijun Sun, Li Deng, Chee-Kwee Ea, Zong-Ping Xia,
Identification and Characterization of an IκB Kinase
Cyclin C/Cdk3 Promotes Rb-Dependent G0 Exit
Volume 9, Issue 5, Pages (November 1998)
Ras Induces Mediator Complex Exchange on C/EBPβ
Robert L.S Perry, Maura H Parker, Michael A Rudnicki  Molecular Cell 
SUMO Promotes HDAC-Mediated Transcriptional Repression
Stefanie S. Schalm, Diane C. Fingar, David M. Sabatini, John Blenis 
Volume 29, Issue 3, Pages (February 2008)
Volume 18, Issue 4, Pages (May 2005)
Volume 93, Issue 7, Pages (June 1998)
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Volume 115, Issue 5, Pages (November 2003)
Volume 93, Issue 5, Pages (May 1998)
A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis
TNF-Induced Activation of the Nox1 NADPH Oxidase and Its Role in the Induction of Necrotic Cell Death  You-Sun Kim, Michael J. Morgan, Swati Choksi, Zheng-gang.
Ligand-Independent Recruitment of SRC-1 to Estrogen Receptor β through Phosphorylation of Activation Function AF-1  André Tremblay, Gilles B Tremblay,
Glycogen Synthase Kinase 3β Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1  Cao-Qi Lei, Bo Zhong, Yu.
Volume 47, Issue 4, Pages (August 2012)
Volume 10, Issue 1, Pages (July 2002)
DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations  William A. Wilmer, Fernando G. Cosio 
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Volume 9, Issue 3, Pages (March 2009)
ER Stress Regulation of ATF6 Localization by Dissociation of BiP/GRP78 Binding and Unmasking of Golgi Localization Signals  Jingshi Shen, Xi Chen, Linda.
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Volume 119, Issue 1, Pages (July 2000)
Volume 39, Issue 2, Pages (July 2010)
EphB/Syndecan-2 Signaling in Dendritic Spine Morphogenesis
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways  Hailing Hsu, Hong-Bing Shu, Ming-Gui Pan, David.
Volume 12, Issue 5, Pages (November 2003)
Volume 96, Issue 6, Pages (March 1999)
Volume 10, Issue 4, Pages (April 1999)
Kimita Suyama, Irina Shapiro, Mitchell Guttman, Rachel B. Hazan 
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
A Ubiquitin Replacement Strategy in Human Cells Reveals Distinct Mechanisms of IKK Activation by TNFα and IL-1β  Ming Xu, Brian Skaug, Wenwen Zeng, Zhijian.
Volume 18, Issue 5, Pages (May 2005)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Casper Is a FADD- and Caspase-Related Inducer of Apoptosis
Volume 91, Issue 2, Pages (October 1997)
Pengbo Zhou, Robert Bogacki, Lisa McReynolds, Peter M. Howley 
Frank S Lee, Jeremiah Hagler, Zhijian J Chen, Tom Maniatis  Cell 
Volume 9, Issue 5, Pages (November 1998)
Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase  Parameswaran Ramakrishnan,
Volume 39, Issue 2, Pages (July 2010)
Volume 2, Issue 4, Pages (October 2002)
Volume 129, Issue 5, Pages (June 2007)
Volume 22, Issue 3, Pages (May 2006)
Volume 10, Issue 2, Pages (February 1999)
Volume 31, Issue 5, Pages (September 2008)
Presentation transcript:

ASK1 Is Essential for JNK/SAPK Activation by TRAF2 Hideki Nishitoh, Masao Saitoh, Yoshiyuki Mochida, Kohsuke Takeda, Hiroyasu Nakano, Mike Rothe, Kohei Miyazono, Hidenori Ichijo  Molecular Cell  Volume 2, Issue 3, Pages 389-395 (September 1998) DOI: 10.1016/S1097-2765(00)80283-X

Figure 1 Activation and Interaction of ASK1 with TRAF Family Proteins (A) Activation of ASK1 by TRAF proteins. HA-tagged ASK1 expression plasmid (pcDNA3-HA-ASK1) (1 μg; lanes 2–7) was transiently cotransfected with Flag-tagged TRAF expression plasmid (pRK-Flag-TRAF1 and -TRAF2, and pCR3-Flag-TRAF3, -TRAF5, and -TRAF6) (1 μg; lanes 3–7) into 293 cells. After 12 hr, ASK1 was immunoprecipitated by anti-HA antibody. The immune complex was incubated with GST-MKK6, and then the kinase activity was measured with the substrate GST-p38γKN. Samples were analyzed by SDS-PAGE (8.5%) and an image analyzer. Top, in vitro kinase assay (IVK) for ASK1 activity. Bottom, immunoblotting (WB) of immunoprecipitated HA-ASK1 in the same sample. Kinase activity relative to the amount of ASK1 protein was calculated, and the activity is shown as fold increase relative to that of HA-ASK1 from TRAF-negative cells (lane 2). (B) Interaction of ASK1 with TRAF proteins. pcDNA3-HA-ASK1 (1 μg; lanes 2, 4, 6, 8, 10, and 12) was transiently cotransfected with each TRAF expression vector (1 μg; lanes 3–12) into 293 cells. After 36 hr, transfected cells were extracted with lysis buffer and immunoprecipitated (IP) with anti-Flag antibody, and immunoblotted (WB) with anti-HA antibody (top). The presence of Flag-TRAF (middle) and HA-ASK1 (bottom) in the same lysates is shown. Markers of molecular mass are shown on the left. (C) Specific interaction of ASK1 with TRAF2. 293 cells were transiently cotransfected with pcDNA3-HA-ASK1 (1 μg; lanes 1–4) and pRK-Flag-TRAF2 (1 μg; lanes 2 and 4). Lysates were divided and immunoprecipitated with anti-Flag antibody (lanes 1 and 2) or control antibody (lanes 3 and 4). The interaction was detected by immunoblotting with anti-HA antibody and anti-Flag antibody. The presence of HA-ASK1 and Flag-TRAF2 in the same lysates was verified by immunoblotting. Molecular Cell 1998 2, 389-395DOI: (10.1016/S1097-2765(00)80283-X)

Figure 2 Binding Sites between TRAF2 and ASK1 (A) Schematic representation of wild-type and mutant TRAF2 proteins. Their abilities to interact with and activate ASK1 when cotransfected into 293 cells are shown. (+), activation of or interaction with ASK1. (−), lack of such activities. (B) Interaction of ASK1 with wild-type and mutant TRAF2. pcDNA3-HA-ASK1 (1 μg; lanes 2, 4, 6, and 8) was transiently cotransfected into 293 cells with expression plasmids for Flag-tagged wild-type and mutant TRAF2 (1 μg; lanes 3–10). Lysates were immunoprecipitated and immunoblotted as described in Figure 1B. (C) Schematic representation of wild-type and mutant ASK1 proteins. The kinase domain is shown by the hatched boxes. ASK1KM represents a catalytically inactive mutant in which Lys-709 has been replaced by Met. Positive interaction with wild-type TRAF2 in 293 cells is shown by a (+). (D) Interaction of TRAF2 with wild-type and mutant ASK1. pRK-Flag-TRAF2 (1 μg; lanes 2, 4, 6, 8, and 10) was transiently cotransfected into 293 cells with HA-tagged wild-type and mutant ASK1 (1 μg; lanes 3–10). Lysates were immunoprecipitated and immunoblotted as described in Figure 1B. Markers of molecular mass are shown on the left. Molecular Cell 1998 2, 389-395DOI: (10.1016/S1097-2765(00)80283-X)

Figure 3 Dominant-Negative Effects of TRAF2 and ASK1 Mutants in TNF-Induced JNK Pathway (A) Inhibition of the TNF-induced activation of ASK1 by a dominant-negative TRAF2 mutant. Indicated amounts of pRK-Flag-TRAF2(87–501) were transiently cotransfected into 293 cells with pcDNA3-HA-ASK1 (1 μg). After 12 hr, the cells were incubated with (+) or without (−) TNF (200 ng/ml) for 15 min. ASK1 was immunoprecipitated with anti-HA antibody and assayed for kinase activity as described in Figure 1A. Top, phosphorylation of GST-p38γKN. Middle, immunoblotting of immunoprecipitated HA-ASK1 in the same sample. Bottom, immunoblotting of Flag-TRAF2(87–501) in the same lysate. Kinase activity relative to the amount of ASK1 protein is shown as fold increase relative to that of HA-ASK1 from TRAF2(87–501)- and TNF-negative cells (lane 2). (B) ASK1KM inhibits TNF-induced JNK activation. HA-tagged JNK expression plasmid (pcDNA3-HA-JNK; 1 μg; lane 2–6) was transiently cotransfected into 293 cells with the indicated amounts of ASK1KM expression plasmid (pcDNA3-ASK1KM; lane 3, 5, and 6). After 12 hr, cells were treated with TNF (200 ng/ml) for 15 min. Immunoprecipitated HA-JNK activity was measured by GST-cJUN phosphorylation as a direct substrate for JNK. Samples were analyzed by SDS-PAGE (10%) and an image analyzer. Expression of ASK1KM was verified by the immunoblotting with anti-ASK1 antiserum (DAV). Top, phosphorylation of GST-cJUN. Middle, immunoblotting of HA-JNK in the same sample. Bottom, expression of ASK1KM in the same lysate. Kinase activity relative to the amount of JNK protein is shown as fold increase relative to that of HA-JNK from ASK1KM- and TNF-negative cells (lane 2). (C) ASK1KM inhibits TRAF2-induced JNK activation. 293 cells were transiently cotransfected with pcDNA3-HA-JNK (2 μg; lane 2–7), pcDNA3-Flag-TRAF2 (0.25 μg; lane 4–7), and the indicated amounts of pcDNA3-ASK1KM (lane 3, 5–7). The relative kinase activity of JNK was determined by immune complex kinase assay as described in (B). Molecular Cell 1998 2, 389-395DOI: (10.1016/S1097-2765(00)80283-X)

Figure 4 TNF-Dependent Endogenous Interaction between ASK1 and TRAF2 (A) Identification of endogenous ASK1 protein in mouse L929 cells. Lysate from L929 cells (2 × 108) was immunoprecipitated with the polyclonal anti-ASK1 antiserum (DAV) with (+) or without (−) blocking peptide (5 μg/ml) against the antiserum, and immunoblotted with DAV. Arrowheads indicate two major ASK1 proteins. Another specific band with an apparent size of 120 kDa may represent a degradation product of ASK1 or an unidentified ASK1-related molecule. Markers of molecular mass are shown on the left. (B) TNF-induced interaction of ASK1 with TRAF2. L929 cells (2 × 108) were treated with TNF (200 ng/ml) for the indicated time periods (lanes 1 and 3–6) or left untreated (lane 2). Cell lysates were immunoprecipitated with the nonimmune antiserum (lane 1) or the polyclonal anti-TRAF2 antiserum (lanes 2–6). Copurified ASK1 proteins were detected by immunoblotting with anti-ASK1 antiserum (top). Arrowheads indicate ASK1 proteins that specifically associated with endogenous TRAF2. Consistent expression of ASK1 (middle) and TRAF2 (bottom) after TNF treatment was confirmed by immunoblotting using similarly treated cell lysates. This experiment was performed four times with similar results. (C) TNF-specific interaction of ASK1 with TRAF2. L929 cells (2 × 108) were exposed for 15 min to TNF (200 ng/ml; lane 2), IL-1α (100 ng/ml; lane 3), or H2O2 (1 mM; lane 4). Coimmunoprecipitated ASK1 (top) with TRAF2 was determined as described in Figure 5B. The presence of ASK1 and TRAF2 proteins in the same lysate was verified by the immunoblotting. The endogenous ASK1 from similarly treated cells was immunoprecipitated by DAV, and the kinase activity was measured (bottom) as described in Figure 1A. Molecular Cell 1998 2, 389-395DOI: (10.1016/S1097-2765(00)80283-X)

Figure 5 Schematic Representation of the Role of ASK1 in TNF Signaling See text for details. Molecular Cell 1998 2, 389-395DOI: (10.1016/S1097-2765(00)80283-X)